ESLA   $1.84  -0.54% Market Closed After Close 1.7603 -4.33%

Estrella Immunopharma, Inc.
Total Cash 4.17M
totalCashPerShare 0.115
EBITDA
Total Debt 4.00K
quickRatio 23.051
currentRatio 24.649
Total Revenue
debtToEquity 0.094
Revenue/Share
ROA -1.22118
ROE
grossProfits
freeCashflow -12.95M
operatingCashflow -16.07M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 22.11M
forwardPE
floatShares 9.94M
sharesOutstanding 36.19M
sharesShort 15.08K
sharesShortPriorMonth 9.59K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.72%
heldPercentInstitutions 0.00%
Short Ratio help_outline 1.10%
shortPercentOfFloat
impliedSharesOutstanding
bookValue 0.118
Price To Book help_outline 6.15
earningsQuarterlyGrowth
netIncomeToCommon -7.31M
trailingEps -0.27%
forwardEps
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 9
lastUpdated Nov. 2, 2024, 6:40 a.m.